| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
2 companies
Leila Alland is Director at ABEO, with reported holdings spanning 2 companies. From April 2021 to June 2026, the filings on record show 1 open-market purchase and 11 sales. Leila Alland's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $754K at current prices.
Our model assigns Leila Alland a strong insider score of 81/100, based on 12 past trades. Over a 12-month horizon, 90.0% of those trades were profitable, with an average 12-month return of +43.6%.
Leila Alland's largest disclosed position is in ABEO as Director, worth about $691K. The ABEO filings lean toward selling, a net 25,311 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 4,000 | $34.83 | $139,308.88 | - | +4.1% | -63.5% | |
| Apr 7, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 4,000 | $33.86 | $135,444.59 | - | -2.6% | -35.4% |